Bumper Offer - Urjas oil Just @ Rs. 1 X
Basalog Injection 3ml (1) is a commercial drug that is prescribed in the form of Injection. It is typically used for the treatment of Diabetes Type 1, Diabetes Type 2. Basalog Injection 3ml (1) also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Basalog Injection 3ml (1). Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Basalog Injection 3ml (1) can also lead to other problems, which have been listed below. Usually, these side effects of Basalog Injection 3ml (1) go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Basalog Injection 3ml (1)'s effect during pregnancy is Safe and Mild while nursing. Warnings related to Basalog Injection 3ml (1)'s effects on the liver, heart and kidney, if any, have been listed below.
The section on Basalog Injection 3ml (1) contraindications lists all such conditions.
Drug interactions for Basalog Injection 3ml (1) have been reported in the medical literature. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Basalog Injection 3ml (1) is considered not safe while driving, and is not addictive.
Basalog Injection 3ml (1) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Basalog Injection 3ml (1) is used -
Moderate
Mild
Is the use of Basalog Injection 3ml (1) safe for pregnant women?
There are no side effects of Basalog in pregnant women.
Is the use of Basalog Injection 3ml (1) safe during breastfeeding?
Basalog may have very limited harmful effects for breastfeeding women.
What is the effect of Basalog Injection 3ml (1) on the Kidneys?
There can be some harmful effects on your kidneys after taking Basalog. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Basalog Injection 3ml (1) on the Liver?
Basalog may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Basalog Injection 3ml (1) on the Heart?
Basalog is rarely harmful for the heart.
Basalog Injection 3ml (1) should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Basalog Injection 3ml (1) unless your doctor advises you to do so -
Is this Basalog Injection 3ml (1) habit forming or addictive?
No, you will not get addicted to Basalog Injection 3ml (1).
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Basalog Injection 3ml (1) can make you feel drowsy.
Is it safe?
Yes, but consume Basalog Injection 3ml (1) only on doctor's advice.
Is it able to treat mental disorders?
No, Basalog Injection 3ml (1) cannot treat any kind of mental disorder.
Interaction between Food and Basalog Injection 3ml (1)
Due to the absence of research, it is difficult to say how Basalog Injection 3ml (1) and food will interact.
Interaction between Alcohol and Basalog Injection 3ml (1)
Side effects of drinking alcohol and taking Basalog Injection 3ml (1) at the same time are rare and minor. However, if you face any side effects, talk to your doctor immediately.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 265
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lantus® (insulin glargine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Soliqua (insulin glargine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 265
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lantus® (insulin glargine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Soliqua (insulin glargine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 265
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lantus® (insulin glargine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Soliqua (insulin glargine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 265
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lantus® (insulin glargine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Soliqua (insulin glargine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 265
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lantus® (insulin glargine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Soliqua (insulin glargine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 265
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lantus® (insulin glargine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Soliqua (insulin glargine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 265
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lantus® (insulin glargine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Soliqua (insulin glargine)